Walker, U., Kirschfink, M., & Peter, H. (2003). Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation. Rheumatology, 42(2), . https://doi.org/10.1093/rheumatology/keg076
Chicago Style (17th ed.) CitationWalker, Ulrich, Michael Kirschfink, and Hans-Hartmut Peter. "Improvement of Acquired Partial Lipodystrophy with Rosiglitazone Despite Ongoing Complement Activation." Rheumatology 42, no. 2 (2003). https://doi.org/10.1093/rheumatology/keg076.
MLA (9th ed.) CitationWalker, Ulrich, et al. "Improvement of Acquired Partial Lipodystrophy with Rosiglitazone Despite Ongoing Complement Activation." Rheumatology, vol. 42, no. 2, 2003, https://doi.org/10.1093/rheumatology/keg076.
Warning: These citations may not always be 100% accurate.